this is very time sensitive – the debate in the EP is today, wed.and vote tomorrow

 The scientific foundations of Europe’s key cancer prevention strategy are coming under renewed examination following reports of possible discord among some MEPs on measures proposed under  Europe’s Beating Cancer Plan (BECA).

Concerns are, according to some media outlets, said to relate to several national EPP delegations questioning whether certain preventive measures adequately reflect scientific research, differences in health risks and the principle of proportionality.

The discussion comes at a time when European health authorities are increasingly drawing attention to the relationship between cancer and poor food quality and nutrition.

For health researchers, the significance of these factors is well established. The WHO and International Agency for Research on Cancer estimate that approximately 37% of new cancer cases worldwide were attributable to preventable causes.

Obesity is one of the challenges facing European health systems. According to  Eurostat figures released in September 2026, more than half of EU adults were overweight in 2025, with 16.3% classified as living with obesity.

The consequences extend beyond diabetes and cardiovascular conditions. IARC has identified sufficient evidence linking excess body fat to at least 13 types of cancer, including colorectal, kidney and postmenopausal breast cancers.

Nutrition has consequently become an increasingly important component of Europe’s approach to preventing chronic diseases.

The latest European Code Against Cancer recommends maintaining a healthy body weight, eating a balanced diet, limiting sugary beverages and certain ultra-processed foods, and engaging in regular physical activity.

These recommendations reflect the growing body of research examining how dietary patterns influence long-term health.

Ultra-processed foods have attracted particular attention, although scientists continue to investigate the extent to which processing itself, rather than nutritional composition or its contribution to excess weight, influences cancer development.

This distinction is important for policymakers considering how to translate nutritional research into public-health interventions.

The European Commission has already begun examining these issues through its wider cardiovascular health agenda. Its Safe Hearts Plan includes initiatives intended to encourage healthier food choices, strengthen consumer information and support product reformulation.

In June, the European Parliament’s Public Health Committee also called for improved nutrition labelling and further assessment of ultra-processed foods as part of a broader effort to reduce cardiovascular disease.

However, the reported disagreements over BECA have renewed discussion about how evidence is assessed across different disease prevention strategies.

One concern is that the approach taken in BECA may not fully reflect the principles emphasized during earlier discussions on cardiovascular disease.

Both conditions have overlapping risk factors, making the relationship between the two strategies particularly relevant to researchers and policymakers examining prevention.

While cancer and cardiovascular disease require different clinical approaches, the importance of healthier diets, weight management and physical activity provides opportunities for coordinated action.

The debate also raises practical questions about the effectiveness of existing measures. Evaluating nutritional education, prevention campaigns, screening programmes and interventions targeting unhealthy consumption patterns could help policymakers identify where additional action would produce meaningful benefits.

At the same time, differences in the strength of scientific evidence across individual risk factors highlight the importance of assessing each proposed intervention on its own merits.

All this is very timely as the European Parliament is set to debate BECA on November 11, ahead of its scheduled vote on November 12.

For many there is a fundamental challenge for EU health policy: ensuring that two major prevention strategies are not advancing contradictory approaches to the same health risks.

With the cardiovascular disease framework already adopted, the question is whether BECA should be amended to reflect the same principles of scientific evidence, differentiated risk and proportionality. Both strategies address overlapping risk factors, and inconsistencies between them could undermine efforts to develop a coherent European approach to disease prevention.

Aligning BECA with the established cardiovascular framework would provide an opportunity to strengthen policy consistency while ensuring that cancer prevention measures remain grounded in scientific evidence and deliver measurable public-health benefits.